Confluent Medical Technologies Names Matthew K. Eckl as Chief Financial Officer
Scottsdale, AZ, October 17, 2022 – Confluent Medical Technologies, Inc. (“Confluent”) today announced that Matthew K. Eckl, has been appointed as Chief Financial Officer (“CFO”) for the company, effective October 17, 2022. “We are thrilled to welcome Matt to Confluent,” said Dean Schauer, Confluent’s Chief Executive Officer. “Matt has exceptional experience in finance and financial ...continue reading